FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387386004: Aztreonam (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461564011 Aztreonam (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481482019 Aztreonam en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492031013 Azthreonam en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492032018 SQ 26,776 en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
51271000195115 aztreonam it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
793151000172117 aztréonam fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65491000195111 Aztreonam de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aztreonam (substance) Is a Substance with beta-lactam structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Aztreonam (substance) Is a Monobactam (substance) true Inferred relationship Some
Aztreonam (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Aztreonam measurement Component True Aztreonam (substance) Inferred relationship Some 1
Monobactam adverse reaction Causative agent (attribute) False Aztreonam (substance) Inferred relationship Some
Aztreonam adverse reaction Causative agent (attribute) True Aztreonam (substance) Inferred relationship Some 1
Allergy to aztreonam (finding) Causative agent (attribute) False Aztreonam (substance) Inferred relationship Some
Aztreonam 500 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aztreonam (substance) Inferred relationship Some
Aztreonam 1 g powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aztreonam (substance) Inferred relationship Some
Aztreonam 2 g powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aztreonam (substance) Inferred relationship Some
Product containing aztreonam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 20mg/mL injection solution 50mL plastic container The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aztreonam (substance) Inferred relationship Some
Aztreonam 40mg/mL injection solution 50mL plastic container The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aztreonam (substance) Inferred relationship Some
Aztreonam 75mg powder for nebulizer solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Aztreonam (substance) Inferred relationship Some
Allergy to aztreonam (finding) Causative agent (attribute) True Aztreonam (substance) Inferred relationship Some 1
Aztreonam lysine (substance) Is a False Aztreonam (substance) Inferred relationship Some
Aztreonam 500 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 500 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 1 g powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 1 g powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 2 g powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 2 g powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aztreonam (substance) Inferred relationship Some 1
Aztreonam lysine (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Aztreonam (substance) Inferred relationship Some
Aztreonam-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aztreonam (substance) Inferred relationship Some 1
Product containing only aztreonam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aztreonam (substance) Inferred relationship Some 1
Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aztreonam (substance) Inferred relationship Some 1
Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aztreonam (substance) Inferred relationship Some 1
Product containing aztreonam in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 1 g powder for solution for infusion and/or injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aztreonam (substance) Inferred relationship Some 1
Aztreonam 1 g powder for solution for infusion and/or injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aztreonam (substance) Inferred relationship Some 1
Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Aztreonam (substance) Inferred relationship Some 1
Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aztreonam (substance) Inferred relationship Some 1
Aztreonam (as aztreonam lysine) 75 mg powder for inhalation solution vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Aztreonam (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start